Literature DB >> 22718812

Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission.

Asuka Nanbo1, Haruna Terada, Kunihiro Kachi, Kenzo Takada, Tadashi Matsuda.   

Abstract

Epstein-Barr virus (EBV), a human gamma herpesvirus, establishes a life-long latent infection in B lymphocytes and epithelial cells following primary infection. Several lines of evidence indicate that the efficiency of EBV infection in epithelial cells is accelerated up to 10(4)-fold by coculturing with EBV-infected Burkitt's lymphoma (BL) cells compared to infection with cell-free virions, indicating that EBV infection into epithelial cells is mainly mediated via cell-to-cell contact. However, the molecular mechanisms involved in this pathway are poorly understood. Here, we establish a novel assay to assess cell-to-cell contact-mediated EBV transmission by coculturing an EBV-infected BL cell line with an EBV-negative epithelial cell line under stimulation for lytic cycle induction. By using this assay, we confirmed that EBV was transmitted from BL cells to epithelial cells via cell-to-cell contact but not via cell-to-cell fusion. The inhibitor treatments of extracellular signal-regulated kinase (ERK) and nuclear factor (NF)-κB pathways blocked EBV transmission in addition to lytic induction. The blockage of the phosphoinositide 3-kinase (PI3K) pathway impaired EBV transmission coupled with the inhibition of lytic induction. Knockdown of the RelA/p65 subunit of NF-κB reduced viral transmission. Moreover, these signaling pathways were activated in cocultured BL cells and in epithelial cells. Finally, we observed that viral replication was induced in cocultured BL cells. Taken together, our data suggest that cell-to-cell contact induces multiple cell signaling pathways in BL cells and epithelial cells, contributing to the induction of the viral lytic cycle in BL cells and the enhancement of viral transmission to epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718812      PMCID: PMC3416120          DOI: 10.1128/JVI.00712-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.

Authors:  T G Boulton; S H Nye; D J Robbins; N Y Ip; E Radziejewska; S D Morgenbesser; R A DePinho; N Panayotatos; M H Cobb; G D Yancopoulos
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA.

Authors:  K Takada; K Horinouchi; Y Ono; T Aya; T Osato; M Takahashi; S Hayasaka
Journal:  Virus Genes       Date:  1991-04       Impact factor: 2.332

3.  Map of the human MHC.

Authors:  J Trowsdale; J Ragoussis; R D Campbell
Journal:  Immunol Today       Date:  1991-12

4.  Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus.

Authors:  A J Sinclair; P J Farrell
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21.

Authors:  H Yoshiyama; S Imai; N Shimizu; K Takada
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Epstein-Barr-virus-infected nasopharyngeal intraepithelial lymphocytes.

Authors:  Q Tao; G Srivastava; A C Chan; F C Ho
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

7.  Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals.

Authors:  Q Tao; G Srivastava; A C Chan; L P Chung; S L Loke; F C Ho
Journal:  J Med Virol       Date:  1995-01       Impact factor: 2.327

8.  Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4.

Authors:  S Akiyama; H Amo; T Watanabe; M Matsuyama; J Sakamoto; M Imaizumi; H Ichihashi; T Kondo; H Takagi
Journal:  Jpn J Surg       Date:  1988-07

9.  Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.

Authors:  Claire Shannon-Lowe; Martin Rowe
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

10.  Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction.

Authors:  N Sugano; W Chen; M L Roberts; N R Cooper
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

View more
  16 in total

1.  In-cell infection: bringing uninvited guests.

Authors:  Yongchan Lee; Michael Overholtzer
Journal:  Cell Res       Date:  2015-05-08       Impact factor: 25.617

2.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

3.  Microfluidic on-demand droplet generation, storage, retrieval, and merging for single-cell pairing.

Authors:  Hesam Babahosseini; Tom Misteli; Don L DeVoe
Journal:  Lab Chip       Date:  2019-01-29       Impact factor: 6.799

4.  Orderly Steps in Progression of JC Virus to Virulence in the Brain.

Authors:  Edward M Johnson; Margaret J Wortman; Patric S Lundberg; Dianne C Daniel
Journal:  Brain Disord Ther       Date:  2015-07-13

5.  Opportunistic DNA Recombination With Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.

Authors:  Margaret J Wortman; Patric S Lundberg; Ayuna V Dagdanova; Pranav Venkataraman; Dianne C Daniel; Edward M Johnson
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

6.  Significance of Interviral Recombination as Novel Mechanism for Extending Viral Disease Repertoire.

Authors:  Edward M Johnson; Dianne C Daniel
Journal:  Brain Disord Ther       Date:  2016-06-23

Review 7.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

Review 8.  Epstein-Barr Virus (EBV)-associated gastric carcinoma.

Authors:  Hisashi Iizasa; Asuka Nanbo; Jun Nishikawa; Masahisa Jinushi; Hironori Yoshiyama
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

9.  In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.

Authors:  Chao Ni; Yuhui Chen; Musheng Zeng; Rongjuan Pei; Yong Du; Linquan Tang; Mengyi Wang; Yazhuo Hu; Hanyu Zhu; Meifang He; Xiawei Wei; Shan Wang; Xiangkai Ning; Manna Wang; Jufang Wang; Li Ma; Xinwen Chen; Qiang Sun; Hong Tang; Ying Wang; Xiaoning Wang
Journal:  Cell Res       Date:  2015-04-28       Impact factor: 25.617

10.  The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.

Authors:  Caroline F Mohr; Martina Kalmer; Christine Gross; Melanie C Mann; Kai R Sterz; Arnd Kieser; Bernhard Fleckenstein; Andrea K Kress
Journal:  Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.